Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

credit_-_carl_recine__reuters

COVID-19 track and trace app launched in England and Wales after months of delays

September 24, 2020 Medical Communications, Sales and Marketing UK, VOCID-19, app, test and trace

The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays …
News
vitaminsupplementpills

‘Smart drugs’ may contain unapproved pharmaceuticals, according to a new study

September 24, 2020 Sales and Marketing FDA, regulation, smart drugs

Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new …
News
credit_-_reuters

Fujifilm’s Avigan reduces recovery time in non-severe COVID-19 patients

September 23, 2020 Research and Development, Sales and Marketing

Fujifilm has announced promising new Phase 3 findings demonstrating that its antiviral therapy Avigan (favipravir) had a statistically significant impact …
News
shutterstock_38078521

New Lenvima/Keytruda combo data in a range of cancers presented at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO2020, Eisai, Lenvima, MSD, keytruda

New data from two studies investigating the combination of Eisai’s multiple receptor tyrosine kinase inhibitor Lenvima (lenvatinib) and MSD’s blockbuster …
News
800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced ovarian cancer

September 21, 2020 Sales and Marketing AstraZeneca

AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment …
News
800px-temazepam_10mg_tablets-1

Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency

September 21, 2020 Sales and Marketing thyroid, thyroid drugs

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …
News
shutterstock_159488225

Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma

New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …
News
800px-united_airlines_aircraft_taking_off_at_schiphol_airport

CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights

September 21, 2020 Sales and Marketing COVID-19, air travel, coronavirus

The Centers for Disease Control and Prevention has identified nearly 11,000 people who were potentially exposed to coronavirus while flying.  …
News

Opdivo scores NICE recommendation in two non-small cell lung cancer indications

September 17, 2020 Sales and Marketing NICE, lung cancer, opdivo

NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell …
News
shutter

MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn

September 15, 2020 Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma

MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …
News
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
Feature
shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
News
shutterstock_273326141

Gilead scoops up Immunomedics in deal worth $21 billion

September 14, 2020 Sales and Marketing Gilead, Immunomedics, acquisition, pharma

The Board of Directors from both companies have unanimously agreed for Gilead to acquire Immunomedics for $88 per share in …
News
800px-logo_of_the_world_health_organization

World Health Organization reports highest one-day rise in COVID-19 infections

September 14, 2020 Sales and Marketing WHO, coronavirus

The World Health Organization has recorded the largest daily rise of coronavirus infection worldwide since the pandemic began.  This was …
News
800px-pfizer_finland_hq_february_13_2009

Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October

September 14, 2020 Sales and Marketing Pfizer, Pfizer vaccine, Vaccine

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026